4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-24-010509
CHIEF FINANCIAL OFFICER gave up 791 shares (to pay taxes)
- CHIEF FINANCIAL OFFICER acquired 2,694 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ragosa Mark CHIEF FINANCIAL OFFICER | 2024-04-08 | Option exercise | +2,694 | 19,562 | D | ||
| Ragosa Mark CHIEF FINANCIAL OFFICER | 2024-04-08 | Shares withheld for taxes | −791 | $17.90 | $14,159 | 18,771 | D |
| Derivatives | |||||||
| Ragosa Mark CHIEF FINANCIAL OFFICER | 2024-04-04 | Grant or award · Share Option | +33,150 | 33,150 | D | ||
| Ragosa Mark CHIEF FINANCIAL OFFICER | 2024-04-04 | Grant or award · Performance Share Unit | +5,092 | 5,092 | D | ||
| Ragosa Mark CHIEF FINANCIAL OFFICER | 2024-04-04 | Grant or award · Restricted Share Unit | +6,365 | 11,615 | D | ||
| Ragosa Mark CHIEF FINANCIAL OFFICER | 2024-04-08 | Option exercise · Restricted Share Unit | −2,694 | 8,921 | D | ||
Loading xslF345X05/form4-04082024_090417.xml…